PET Imaging as a Tool for Assessing COVID-19 Brain Changes

A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontana, Igor C., Bongarzone, Salvatore, Gee, Antony, Souza, Diogo O., Zimmer, Eduardo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580682/
https://www.ncbi.nlm.nih.gov/pubmed/33131922
http://dx.doi.org/10.1016/j.tins.2020.10.010
Descripción
Sumario:A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.

Ejemplares similares